Pharma major Cadila Healthcare has posted a rise of 15.38% in its consolidated net profit at Rs 229.82 crore for the quarter ended June compared with Rs 199.18 crore in the previous corresponding quarter.
The drug maker's total income during the period rose to Rs 1,252 crore from Rs 1,136.65 crore, up 10.14%.
However, on the standalone-basis, company's net profit stood 23% lower at Rs 152.93 crore compared with Rs 198.64 crore in the corresponding quarter of the previous financial year. Similarly, total standalone income declined to Rs 790.52 crore from Rs 799.11 crore.
On the Bombay Stock Exchange, shares of Cadila were trading at Rs 969.05, up 0.86% at IST 1456.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app